Limits...
Piloting an HIV self-test kit voucher program to raise serostatus awareness of high-risk African Americans, Los Angeles.

Marlin RW, Young SD, Bristow CC, Wilson G, Rodriguez J, Ortiz J, Mathew R, Klausner JD - BMC Public Health (2014)

Bottom Line: We determined feasibility based on: (1) the establishment of a voucher redemption and third-party payment system, (2) the willingness of community-based organizations (CBOs) to disseminate vouchers, and (3) the collection of user demographics, test and linkage-to-care results with an anonymous telephone survey.Two withheld their results, both of whom also sought medical care.Expanded research and evaluation of voucher programs for HIV self-test kits among high-risk groups is warranted.

View Article: PubMed Central - PubMed

Affiliation: Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Le Conte Avenue, Los Angeles, CA, USA. rmarlin@mednet.ucla.edu.

ABSTRACT

Background: Up to half of all new HIV cases in Los Angeles may be caused by the 20-30% of men who have sex with men (MSM) with unrecognized HIV infection. Racial/ethnic minority MSM are at particularly high risk for being sero-unaware and due to stigma and poor healthcare access might benefit from novel private, self-testing methods, such as the recently FDA-approved OraQuick® In-Home HIV Test.

Methods: From July-November 2013, we undertook a pilot study to examine the feasibility of a voucher program for free OraQuick® tests targeting African American MSM in Los Angeles. We determined feasibility based on: (1) the establishment of a voucher redemption and third-party payment system, (2) the willingness of community-based organizations (CBOs) to disseminate vouchers, and (3) the collection of user demographics, test and linkage-to-care results with an anonymous telephone survey.

Results: We partnered with Walgreens® to create a voucher and third-party reimbursement system for free OraQuick® tests. Voucher distribution was divided into two periods. In total, 641 vouchers were supplied to CBOs: 274 (42.7%) went to clients and of those 53 (19.3%) were redeemed. Fifty (18.2%) of the 274 clients were surveyed: 44 (88%) were African American, 39 (78%) reported being likely to repeat voucher use, 44 (88%) reported reviewing pre-test information, and 37 (74%) the post-test information. Three (6%) of 50 survey respondents reported newly testing HIV-positive of whom all (100%) reported seeking medical care. Two withheld their results, both of whom also sought medical care.

Conclusions: Developing and partnering with a commercial pharmacy to institute a voucher system to facilitate HIV self-testing with linkage-to-care was feasible. Our findings suggest the voucher program was associated with increasing the identification of new cases of HIV infection with high rates of linkage to care. Expanded research and evaluation of voucher programs for HIV self-test kits among high-risk groups is warranted.

Show MeSH

Related in: MedlinePlus

Opinions in HIV in-home self-test voucher use survey attitudes (N = 50), Los Angeles, 2013.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4289344&req=5

Fig1: Opinions in HIV in-home self-test voucher use survey attitudes (N = 50), Los Angeles, 2013.

Mentions: Using a Likert scale, 78% of participants reported that they were likely or very likely to use a voucher again, 65% reported that it was easy to travel to a Walgreens to redeem their voucher and 44% preferred self-testing over clinic based testing (26%) (Figure 1). About 22% of participants were uncomfortable or very uncomfortable with the in-store redemption process. One participant noted that the Walgreens staff at the store they visited was confused about the voucher, had to involve the store manager, took longer than expected, and overall the in-store process made the participant feel uncomfortable.Table 1


Piloting an HIV self-test kit voucher program to raise serostatus awareness of high-risk African Americans, Los Angeles.

Marlin RW, Young SD, Bristow CC, Wilson G, Rodriguez J, Ortiz J, Mathew R, Klausner JD - BMC Public Health (2014)

Opinions in HIV in-home self-test voucher use survey attitudes (N = 50), Los Angeles, 2013.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4289344&req=5

Fig1: Opinions in HIV in-home self-test voucher use survey attitudes (N = 50), Los Angeles, 2013.
Mentions: Using a Likert scale, 78% of participants reported that they were likely or very likely to use a voucher again, 65% reported that it was easy to travel to a Walgreens to redeem their voucher and 44% preferred self-testing over clinic based testing (26%) (Figure 1). About 22% of participants were uncomfortable or very uncomfortable with the in-store redemption process. One participant noted that the Walgreens staff at the store they visited was confused about the voucher, had to involve the store manager, took longer than expected, and overall the in-store process made the participant feel uncomfortable.Table 1

Bottom Line: We determined feasibility based on: (1) the establishment of a voucher redemption and third-party payment system, (2) the willingness of community-based organizations (CBOs) to disseminate vouchers, and (3) the collection of user demographics, test and linkage-to-care results with an anonymous telephone survey.Two withheld their results, both of whom also sought medical care.Expanded research and evaluation of voucher programs for HIV self-test kits among high-risk groups is warranted.

View Article: PubMed Central - PubMed

Affiliation: Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Le Conte Avenue, Los Angeles, CA, USA. rmarlin@mednet.ucla.edu.

ABSTRACT

Background: Up to half of all new HIV cases in Los Angeles may be caused by the 20-30% of men who have sex with men (MSM) with unrecognized HIV infection. Racial/ethnic minority MSM are at particularly high risk for being sero-unaware and due to stigma and poor healthcare access might benefit from novel private, self-testing methods, such as the recently FDA-approved OraQuick® In-Home HIV Test.

Methods: From July-November 2013, we undertook a pilot study to examine the feasibility of a voucher program for free OraQuick® tests targeting African American MSM in Los Angeles. We determined feasibility based on: (1) the establishment of a voucher redemption and third-party payment system, (2) the willingness of community-based organizations (CBOs) to disseminate vouchers, and (3) the collection of user demographics, test and linkage-to-care results with an anonymous telephone survey.

Results: We partnered with Walgreens® to create a voucher and third-party reimbursement system for free OraQuick® tests. Voucher distribution was divided into two periods. In total, 641 vouchers were supplied to CBOs: 274 (42.7%) went to clients and of those 53 (19.3%) were redeemed. Fifty (18.2%) of the 274 clients were surveyed: 44 (88%) were African American, 39 (78%) reported being likely to repeat voucher use, 44 (88%) reported reviewing pre-test information, and 37 (74%) the post-test information. Three (6%) of 50 survey respondents reported newly testing HIV-positive of whom all (100%) reported seeking medical care. Two withheld their results, both of whom also sought medical care.

Conclusions: Developing and partnering with a commercial pharmacy to institute a voucher system to facilitate HIV self-testing with linkage-to-care was feasible. Our findings suggest the voucher program was associated with increasing the identification of new cases of HIV infection with high rates of linkage to care. Expanded research and evaluation of voucher programs for HIV self-test kits among high-risk groups is warranted.

Show MeSH
Related in: MedlinePlus